Contact
Please use this form to send email to PR contact of this press release:
OSE Immunotherapeutics Will Participate in HealthTech Investor Days (HTID)
TO:
Please use this form to send email to PR contact of this press release:
OSE Immunotherapeutics Will Participate in HealthTech Investor Days (HTID)
TO: